Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

8 February 2023

CPFT partners largest ever UK trial of mental health treatment for young people

CPFT staff have successfully bid to run a £2.1 million national study, funded by the National Institute for Health and Care Research (NIHR), to investigate how more mental health practitioners can deliver effective interventions to support young people’s mental health. ...

8 February 2023

Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform disrupting genomics, today announced a partnership to demonstrate the capabilities of the...

8 February 2023

H.E.L Group appoints Allen Wang as General Manager of H.E.L China

Appointment follows successful expansion of operations in China and transition to direct sales model Supports next phase in H.E.L’s development as China becomes significant contributor to commercial growth H.E.L Group (H.E.L), a global developer and manufacturer of innovative labo...

8 February 2023

Skills for life: National Apprenticeship Week

Cambridge University Hospitals NHS Foundation Trust says...we’re sharing the stories of some of our apprentices as part of National Apprenticeship Week — and celebrating the positive impact they make to staff and patients at our hospitals. ...

7 February 2023

Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios

New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems

7 February 2023

RSV older adult, elderly vaccines - durability versus combination?

This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a new updated global demand analysis for RSV older adult, elderly vaccines. ...

7 February 2023

Evonetix closes $24 million USD (£20 million) financing

Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24...

6 February 2023

Bio-Rad Showcases Compatibility of SEQuoia™ RNA Library Preparation Kits with New Innovative Sequencers at AGBT 2023

Hercules, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers and announces compatibility of the SEQuoia RNA Sequencing Li...

6 February 2023

Portuguese fertility doctors visit Bourn Hall, the birthplace of IVF treatment

Bourn Hall was delighted to welcome a delegation of Portuguese doctors from leading medical centres to its Cambridge clinic. ...

6 February 2023

Guardtech Group launch new CleanCube Mobile Cleanrooms website

Cleanroom construction company unveil the first of their new Guardtech Group subsidiary subsites for portable solutions ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 204
  • Page 205
  • Current page 206
  • Page 207
  • Page 208
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS